Bone Marrow Derived Stem Cells for Severely reduced Leg Circulation led by Dr. Michael Murphy. Contact through Janet Klein (317-962-0287)
March Laboratory
Mission:
Promote Health through an Understanding and Translation of Adipose Stromal Stem Cells
Director:
Keith L. March, MD, PhD
Background of Director:
Dr. Keith March
Dr. March is Professor of Medicine, Physiology and Biomedical Engineering at the Indiana University School of Medicine and the Krannert Institute of Cardiology. He is the Director of the Indiana Center for Vascular Biology and Medicine as well as Director of the IUPUI “Signature” Vascular and Cardiac Center of Adult Stem Cell Cast (VC-CAST). Dr. March has published more than 75 manuscripts and edited the first book dedicated to cardiovascular gene transfer. He has served as a scientific advisor to numerous pharmaceutical, biotechnology, and medical device companies.
Dr. March is committed to bringing new medical approaches to patients. He invented and patented a device called Closer, a suture-mediated closure device that is used to close the arterial hole following a heart catheterization. This device allows a patient to "walk off the table" after a catheterization without requiring prolonged bed rest. Abbott Vascular, an affiliate of Abbott Laboratories, acquired the company that developed this technology in 1999 and the Closer approach is now used in 500,000 patients worldwide annually. His research has resulted in more than 40 world-wide (19 U.S.) patents, with others pending.
Current Projects:
1.) Adipose Stem Cells Augment Circulation by Secreting Growth Factors as well as Stabilizing Blood Vessels 2.) Adipose Stem Cells Rescue Heart Tissue from Damage
